HLA-C and graft versus host disease: Eight of the top 20 most significantly enriched pathways were involved in HLA-C, namely natural killer cell-mediated cytotoxicity, viral myocarditis, antigen processing and presentation, HTLV-I infection, allograft rejection, graft-versus-host disease, type I diabetes, and autoimmune thyroid disease.